Nixon Peabody Trust’s Zimmer Biomet ZBH Stock Holding History

Nixon Peabody Trust’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$280K	Hold	3,250	–	–	0.02%	160
2026 Q1	$294K	Hold	3,250	–	–	0.02%	139
2025 Q4	$292K	Hold	3,250	–	–	0.02%	135
2025 Q3	$320K	Hold	3,250	–	–	0.02%	132
2025 Q2	$296K	Sell	3,250 -830	-20%	-$80.3K	0.02%	133
2025 Q1	$462K	Buy	4,080 +60	+1%	+$6.42K	0.04%	117
2024 Q4	$425K	Buy	4,020 +20	+0.5%	+$2.15K	0.04%	109
2024 Q3	$432K	Hold	4,000	–	–	0.04%	106
2024 Q2	$434K	Hold	4,000	–	–	0.04%	97
2024 Q1	$528K	Sell	4,000 -120	-3%	-$15K	0.05%	84
2023 Q4	$501K	Buy	+4,120	New	+$460K	0.06%	84

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Nixon Peabody Trust's ZBH Position: Q2 2026 in Review

Nixon Peabody Trust held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 3,250 shares worth $280K. The position accounts for 0.02% of the portfolio, ranked #160.

Nixon Peabody Trust first reported a position in ZBH in Q4 2023 and has held it in 11 quarters since. The position peaked at $528K in Q1 2024. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Nixon Peabody Trust held 3,250 shares of Zimmer Biomet worth $280K as of Q2 2026.
Nixon Peabody Trust left its Zimmer Biomet share count unchanged in Q2 2026.
Zimmer Biomet made up 0.02% of Nixon Peabody Trust's portfolio in Q2 2026, its #160 holding.
Nixon Peabody Trust first reported a position in Zimmer Biomet in Q4 2023 and has held it in 11 quarters since.
Nixon Peabody Trust's Zimmer Biomet position peaked at $528K in Q1 2024.
906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Nixon Peabody Trust's 13F filing for Q2 2026, filed 27 Jul 2026.